Bluebird Bio Inc. buy Robert W. Baird
Start price
12.12.23
/
50%
€2.57
Target price
12.12.24
€6.49
Performance (%)
-66.01%
Price
26.04.24
€0.87
Summary
This prediction is currently active. The BUY prediction by Robert_W__Baird for Bluebird Bio Inc. is performing very badly with a performance of -66.01%. This prediction currently runs until 12.12.24. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bluebird Bio Inc. | -8.293% | -8.293% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Robert_W__Baird for this prediction
In the thread Bluebird Bio Inc. diskutieren
bluebird bio, Inc. (NASDAQ: BLUE) had its price target lowered by analysts at Robert W. Baird from $10.00 to $7.00. They now have an "outperform" rating on the stock.
Ratings data for BLUE provided by MarketBeat